End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100 EGP | 0.00% | 0.00% | 0.00% |
10/03 | October Pharma S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | October Pharma S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Business Summary
At the end of 2020, the group had a production site located in Egypt.
Sales per Business
EGP in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals and Drugs
100.0
%
| 523 | 100.0 % | 543 | 100.0 % | +3.88% |
Sales per region
EGP in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Egypt
100.0
%
| 523 | 100.0 % | 543 | 100.0 % | +3.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Tamer Ahmed
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Corporate Secretary | - | - | |
Comptroller/Controller/Auditor | - | - | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 31/18/31 | |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,000,000 | 1,381,476 ( 11.51 %) | 0 | 11.51 % |
Company contact information
October Pharma Co.
1st Industrial Zone Street 25, 6th of October City
12566, Cairo
+
http://www.octoberpharma.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 25.5M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- OCPH Stock
- Company October Pharma S.A.E